Rafik M Ghobrial

Author PubWeight™ 42.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005 2.64
2 Incisional hernia after liver transplantation. J Am Coll Surg 2006 2.23
3 Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg 2009 2.16
4 Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007 2.12
5 Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005 1.73
6 Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl 2003 1.71
7 Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 2008 1.61
8 Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg 2003 1.58
9 Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004 1.58
10 Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007 1.57
11 Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation. Transpl Int 2013 1.44
12 Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006 1.36
13 Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl 2007 1.20
14 Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl 2004 1.12
15 Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 2002 1.03
16 Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant 2003 0.98
17 Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single institution. J Am Coll Surg 2007 0.97
18 IL-9 and Th9 cells: progress and challenges. Int Immunol 2013 0.94
19 New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg 2002 0.91
20 Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl 2003 0.90
21 Leveraging nanochannels for universal, zero-order drug delivery in vivo. J Control Release 2013 0.89
22 Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells. Folia Histochem Cytobiol 2012 0.84
23 Inhibition of chronic rejection by antibody induced vascular accommodation in fully allogeneic heart allografts. Transplantation 2005 0.81
24 Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance. Transplantation 2003 0.80
25 Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg 2006 0.80
26 Memory T cells in transplantation - progress and challenges. Curr Opin Organ Transplant 2013 0.80
27 Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways. Transplantation 2013 0.80
28 Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. Am J Transplant 2003 0.78
29 Allochimeric molecules and mechanisms in abrogation of cardiac allograft rejection. J Heart Lung Transplant 2011 0.77
30 Pericytes, microvasular dysfunction, and chronic rejection. Transplantation 2015 0.77
31 The Evolving Roles of Memory Immune Cells in Transplantation. Transplantation 2015 0.77
32 Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains. Cell Immunol 2007 0.77
33 Downregulation of RhoA and changes in T cell cytoskeleton correlate with the abrogation of allograft rejection. Transpl Immunol 2010 0.77
34 Intragraft selection of the T cell receptor repertoire by class I MHC sequences in tolerant recipients. PLoS One 2009 0.77
35 Polarity and asymmetry during mouse oogenesis and oocyte maturation. Results Probl Cell Differ 2012 0.76
36 Down regulation of genes involved in T cell polarity and motility during the induction of heart allograft tolerance by allochimeric MHC I. PLoS One 2009 0.76
37 The newly found functions of MTOC in immunological response. J Leukoc Biol 2013 0.75
38 The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation 2016 0.75
39 Intragraft gene expression profile associated with the induction of tolerance by allochimeric MHC I in the rat heart transplantation model. Genesis 2010 0.75